SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-006143
Filing Date
2017-04-06
Accepted
2017-04-06 16:11:30
Documents
8
Period of Report
2017-05-16
Effectiveness Date
2017-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A tndm-def14a_20170510.htm DEF 14A 1050150
2 GRAPHIC g201704051554418912326.jpg GRAPHIC 46331
3 GRAPHIC g201704051554418532324.jpg GRAPHIC 3765
4 GRAPHIC g201704051554326562322.jpg GRAPHIC 5851
5 GRAPHIC g201704051554418652325.jpg GRAPHIC 19605
6 GRAPHIC g201704051554328392323.jpg GRAPHIC 3812
7 GRAPHIC g201704051554326312321.jpg GRAPHIC 74084
8 GRAPHIC g201704051554419192327.jpg GRAPHIC 80820
  Complete submission text file 0001564590-17-006143.txt   1374864
Mailing Address 11045 ROSELLE STREET SUITE 200 San Diego CA 92121
Business Address 11045 ROSELLE STREET SUITE 200 San Diego CA 92121 858-366-6900
TANDEM DIABETES CARE INC (Filer) CIK: 0001438133 (see all company filings)

IRS No.: 204327508 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36189 | Film No.: 17746086
SIC: 3841 Surgical & Medical Instruments & Apparatus